Physician profile
Michele Barbara Berkeley
NPI 1144229170
$1,588.27
in general payments reported to CMS, 2019-2025
14 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $158 · 2021: $20.00 · 2022: $55.75 · 2023: $464 · 2024: $103 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $875.69 | 2020-2025 | Acessa Provu System |
| Abbvie INC. | $240.61 | 2019-2020 | |
| Daiichi Sankyo INC. | $197.87 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.41 | 2019-2020 | |
| Therapeuticsmd, INC. | $37.47 | 2019 | |
| Merck Sharp & Dohme LLC | $33.94 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.48 | 2020 | |
| Virtus Pharmaceuticals LLC | $20.00 | 2021 | |
| Duchesnay USA Incorporated | $19.44 | 2019 | |
| Lupin INC. | $14.92 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.82 | 2019 | |
| Millicent US INC | $13.51 | 2019 | |
| Avion Pharmaceuticals | $11.70 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Berkeley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.